Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis
Philip O. Scumpia(University of California, Los Angeles), Lyle L. Moldawer(University of Florida), Matthew J. Delano(University of Michigan), Kindra M. Kelly‐Scumpia(University of California, Los Angeles), Westley H. Reeves(University of Florida Health), James L. Wynn(University of Florida), Robert D. Winfield, Jason S. Weinstein(Rutgers, The State University of New Jersey), Mark A. Atkinson(University of Florida), Chang‐Qing Xia(University of Florida), Alfred Ayala(Brown University), Chun S. Chung(Brown University), Michael Clare‐Salzler(Montreal Neurological Institute and Hospital)
Cited by 84
Related Papers
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
Type 1 diabetes
|The Lancet|2013|2.7k
Sepsis and septic shock
|Nature Reviews Disease Primers|2016|1.6k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k